investor.enzon.comInvestor Relations | Enzon Pharmaceuticals
investor.enzon.com Profile
investor.enzon.com
Maindomain:enzon.com
Title:Investor Relations | Enzon Pharmaceuticals
Description:Skip to main navigation HOME ABOUT ENZON ROYALTY PRODUCTS INVESTORS & MEDIA Investor Relations Press Releases Corporate Governance SEC Filings Stock Quote Stock Lookup Contact Us CONTACT US Reques
Discover investor.enzon.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
investor.enzon.com Information
Website / Domain: |
investor.enzon.com |
HomePage size: | 25.193 KB |
Page Load Time: | 0.820378 Seconds |
Website IP Address: |
23.52.0.114 |
Isp Server: |
Akamai International BV |
investor.enzon.com Ip Information
Ip Country: |
Germany |
City Name: |
Neu Isenburg |
Latitude: |
50.048320770264 |
Longitude: |
8.6940603256226 |
investor.enzon.com Keywords accounting
investor.enzon.com Httpheader
Accept-Ranges: bytes |
Content-Encoding: gzip |
Content-Language: en |
Content-Security-Policy: report-uri //report-csp-violation |
Content-Type: text/html; charset=UTF-8 |
device: desktop |
ETag: "1581605021" |
From-Origin: same |
Last-Modified: Thu, 13 Feb 2020 14:43:41 GMT |
Link: http://investor.enzon.com/; rel="shortlink", http://investor.enzon.com/; rel="canonical", https://investor.enzon.com/investor-relations; rel="alternate"; hreflang="en", https://investor.enzon.com/investor-relations; rel="revision" |
Server: nginx |
X-Age: 0 |
X-Content-Security-Policy: report-uri //report-csp-violation |
X-Content-Type-Options: nosniff |
X-Drupal-Dynamic-Cache: UNCACHEABLE |
X-Frame-Options: SAMEORIGIN |
X-Generator: Drupal 8 (https://www.drupal.org) |
X-Request-ID: v-3a605f7a-4e6f-11ea-ab8a-5736289fb213 |
X-UA-Compatible: IE=edge |
X-WebKit-CSP: report-uri //report-csp-violation |
X-XSS-Protection: 1; mode=block |
X-EdgeConnect-MidMile-RTT: 1, 15 |
X-EdgeConnect-Origin-MEX-Latency: 328, 328 |
X-Akamai-Transformed: 9 7339 0 pmb=mRUM,1 |
Cache-Control: public, max-age=0, s-maxage=1800 |
Expires: Thu, 13 Feb 2020 14:43:41 GMT |
Date: Thu, 13 Feb 2020 14:43:41 GMT |
Content-Length: 7770 |
Connection: keep-alive |
Vary: Accept-Encoding |
Set-Cookie: SimpleSAMLSessionID=4b994edd25ca363163341f0e739c7ed8; path=/; secure; HttpOnly, DrupalVisitorMobile=0; path=/ |
Strict-Transport-Security: max-age=15768000 ; preload |
investor.enzon.com Meta Info
charset="utf-8"/ |
content="Investor Relations | Enzon Pharmaceuticals" name="title"/ |
content="Enzon Pharmaceuticals" property="og:site_name"/ |
content="website" property="og:type"/ |
content="no-referrer" name="referrer"/ |
content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
content="width" name="MobileOptimized"/ |
content="true" name="HandheldFriendly"/ |
content="width=device-width, initial-scale=1.0" name="viewport"/ |
content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
23.52.0.114 Domains
investor.enzon.com Similar Website
Domain |
WebSite Title |
ir.supernus.com | Investor Relations - Supernus Pharmaceuticals |
investors.vrtx.com | Investor Relations | Vertex Pharmaceuticals |
investors.amneal.com | Amneal Pharmaceuticals Inc - Investor Relations |
ir.alexion.com | Investor Relations | Alexion Pharmaceuticals, Inc. |
investor.eagleus.com | Eagle Pharmaceuticals Investor Center | |
investor.enzon.com | Investor Relations | Enzon Pharmaceuticals |
investor.sppirx.com | Investor Relations - Spectrum Pharmaceuticals, Inc. |
investor.regeneron.com | Investor Relations | Regeneron Pharmaceuticals Inc. |
investors.aeriepharma.com | Investor Relations | Aerie Pharmaceuticals, Inc |
ir.progenics.com | Investor Relations | Progenics Pharmaceuticals, Inc. |
newsroom.regeneron.com | Investor Relations | Regeneron Pharmaceuticals Inc. |
ir.titanpharm.com | Investor Relations :: Titan Pharmaceuticals, Inc. (TTNP) |
investor.ligand.com | Investor Summary :: Ligand Pharmaceuticals Incorporated (LGND) |
zuchepharma.trustpass.alibaba.com | ZUCHE PHARMACEUTICALS PRIVATE LIMITED - Pharmaceuticals,Medical Devices |
aeriepharma.com | Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals |
investor.enzon.com Traffic Sources Chart
investor.enzon.com Alexa Rank History Chart
investor.enzon.com Html To Plain Text
Skip to main navigation HOME ABOUT ENZON ROYALTY PRODUCTS INVESTORS & MEDIA Investor Relations Press Releases Corporate Governance SEC Filings Stock Quote Stock Lookup Contact Us CONTACT US Request Information Email Alerts Download Library RSS News Feeds Shareholder Tools Investor Relations Enzon Pharmaceuticals, Inc. manages its sources of royalty revenues from existing licensing arrangements with other companies primarily related to sales of certain drug products that utilize our proprietary technology. Stock Quote: ENZN Exchnage OT Price Change Volume Feb 13, 2020 9:43 AM EST. 15 minute delayed data Provided by NASDAQ ©2017 Enzon Pharmaceuticals, Inc., All Rights Reserved....
investor.enzon.com Whois
"domain_name": "ENZON.COM",
"registrar": "GoDaddy.com, LLC",
"whois_server": "whois.godaddy.com",
"referral_url": null,
"updated_date": [
"2018-01-04 22:12:13",
"2018-01-04 22:12:12"
],
"creation_date": "1996-02-18 05:00:00",
"expiration_date": "2023-02-19 05:00:00",
"name_servers": [
"NS0.DNSMADEEASY.COM",
"NS1.DNSMADEEASY.COM",
"NS2.DNSMADEEASY.COM",
"NS3.DNSMADEEASY.COM",
"NS4.DNSMADEEASY.COM"
],
"status": [
"clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited",
"clientRenewProhibited https://icann.org/epp#clientRenewProhibited",
"clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited",
"clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited",
"clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited",
"clientRenewProhibited http://www.icann.org/epp#clientRenewProhibited",
"clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited"
],
"emails": "abuse@godaddy.com",
"dnssec": "unsigned",
"name": null,
"org": "Enzon Pharmaceuticals Inc",
"address": null,
"city": null,
"state": "New Jersey",
"zipcode": null,
"country": "US"